AC Immune SA (ACIU) stock

ACIUNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 13, 2026Score 3/30

$2.13−0.01 (-0.47%)

Close on Nov 13, 2026Market cap $216.71MP/E –Yield –

AC Immune EPS

Diluted earnings per share is net income divided by the share count including options and convertible securities.

AC Immune's EPS for the twelve months ending Dec 31, 2022 was -0.85 CHF. For fiscal 2025 it was -0.70 CHF. The highest annual figure on record is 0.64 CHF in fiscal 2019.

Annual eps

Period	Period end	Value	Change
FY2025	Dec 31, 2025	-0.70 CHF	–
FY2024	Dec 31, 2024	-0.51 CHF	–
FY2023	Dec 31, 2023	-0.64 CHF	–
FY2022	Dec 31, 2022	-0.85 CHF	–
FY2021	Dec 31, 2021	-0.97 CHF	–
FY2020	Dec 31, 2020	-0.86 CHF	-234.4%
FY2019	Dec 31, 2019	0.64 CHF	–
FY2018	Dec 31, 2018	-0.82 CHF	–
FY2017	Dec 31, 2017	-0.46 CHF	–
FY2016	Dec 31, 2016	-0.14 CHF	-131.8%
FY2015	Dec 31, 2015	0.44 CHF	–

Quarterly eps

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q2 FY2025	Jun 30, 2025	-0.21 CHF	–
Q2 FY2024	Jun 30, 2024	-0.23 CHF	–
Q2 FY2023	Jun 30, 2023	-0.20 CHF	–
Q4 FY2022	Dec 31, 2022	-0.22 CHF	–
Q3 FY2022	Sep 30, 2022	-0.16 CHF	–
Q2 FY2022	Jun 30, 2022	-0.23 CHF	–
Q4 FY2021	Dec 31, 2021	-0.26 CHF	–
Q3 FY2021	Sep 30, 2021	-0.22 CHF	–
Q4 FY2018	Dec 31, 2018	-0.22 CHF	-414.3%
Q3 FY2018	Sep 30, 2018	-0.21 CHF	–
Q2 FY2018	Jun 30, 2018	-0.19 CHF	–
Q1 FY2018	Mar 31, 2018	-0.20 CHF	–
Q4 FY2017	Dec 31, 2017	0.07 CHF	–
Q3 FY2017	Sep 30, 2017	-0.15 CHF	–
Q2 FY2017	Jun 30, 2017	-0.22 CHF	–
Q1 FY2017	Mar 31, 2017	-0.17 CHF	–